Learn more about our programs
Ovarian

What’s PARP? Getting Up to Speed on New Strategies to Delay Progression of Ovarian Cancer

Live on Wednesday, February 24, 2021
from 10:00 AM – 11:00 AM ET

Register

Thank you to our partner, Sharsheret.
Support for this patient education program was provided by an educational grant from GlaxoSmithKline.

Do you know if you are receiving the most effective treatment for your ovarian cancer? What questions should you ask your doctor about preventive options or new therapeutic approaches?

PARP inhibitors offer a new option to delay the progression of ovarian cancer and improve overall quality of life for patients. However, patients need a clear understanding of the benefits of these treatment options, the goals of maintenance therapy, and how PARP inhibition fits into their treatment plan.

Join expert clinicians and fellow patients for a 60-minute educational presentation: “What’s PARP? Getting Up to Speed on New Strategies to Delay Progression of Ovarian Cancer.” A patient panelist and real-life patient insights will ensure your concerns are addressed during discussions of maintenance therapy and treatment with PARP inhibitors. You will also learn about the side-effects you might experience with PARP inhibitors, to help you recognize and prepare for them. Sources of support and advice from other patients and expert medical organizations will also be shared.

Have any questions? Submit them to the Q-Board to have them considered for future programs

Register to attend the program live or watch later on-demand.

 

Speakers

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology, Dana-Farber Cancer Institute

Courtney Arn, APRN-CNP

Wexner Medical Center, The Ohio State University

Barbara Reeves

Patient Interview Speaker

Patti Smith

Patient Interview Speaker

 

Partners

  • Sharsheret. logo